Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers with unclear genetic foundation. Genetic association studies with large cohort were extensively performed but not for East Asian population especially for Chinese Population. To date, little is known about racial disparities in the genetic landscape of PDAC. Significantly higher rate of EGFR mutation in Chinese lung cancer patients bring about a new era of lung cancer treatment, leading to a remarkably improved survival. Therefore, understanding the distinct genetic features of PDAC in Chinese population is warranted and could possibly change the paradigm of PDAC management.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.